Screening for pulmonary hypertension in interstitial lung disease: Many reasons to ECHO!

Abstract

http://onlinelibrary.wiley.com/doi/10.1111/resp.13250/abstract

Contemporary Concise Review 2018: Interstitial lung disease

“…Co‐morbidities have a great impact on ILD survival . In particular, the role of pulmonary hypertension (PH) was investigated in the last year because, despite the general improvement of PH survival in the last decade, management in the context of ILD disease remains difficult as well as the discordance between transthoracic echocardiography (TTE) and the right heart catheter (RHC) is nowadays progressively recognized . Recently, additional subtypes of ILD with autoimmune features were defined making the role of rheumatological assessment increasingly important to improve the diagnostic accuracy .…”